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ABSTRACT
A method for the isolation of genomic fragments of
RNAvirusbasedoncDNArepresentationaldifference
analysis (cDNA RDA) was developed. cDNA RDA has
been applied for the subtraction of poly(A)
1 RNAs
but not for poly(A)
  RNAs, such as RNA virus gen-
omes, owing to the vast quantity of ribosomal RNAs.
We constructed primers for inefficient reverse tran-
scription of ribosomal sequences based on the dis-
tribution analysis of hexanucleotide patterns in
ribosomal RNA. The analysis revealed that distribu-
tions of hexanucleotide patterns in ribosomal RNA
and virus genome were different. We constructed 96
hexanucleotides (non-ribosomal hexanucleotides)
andusedthemasmixedprimersforreversetranscrip-
tion of cDNA RDA. A synchronous analysis of hexa-
nucleotidepatternsinknownviralsequencesshowed
that all the known genomic-size viral sequences
include non-ribosomal hexanucleotides. In a model
experiment, when non-ribosomal hexanucleotides
were used as primers, in vitro transcribed plasmid
RNA was efficiently reverse transcribed when com-
pared with ribosomal RNA of rat cells. Using non-
ribosomal primers, the cDNA fragments of severe
acute respiratory syndrome coronavirus and bovine
parainfluenza virus 3 were efficiently amplified
by subtracting the cDNA amplicons derived from
uninfected cells from those that were derived from
virus-infected cells. The results suggest that cDNA
RDA with non-ribosomal primers can be used for
species-independent detection of viruses, including
new viruses.
INTRODUCTION
Identifying the causative agent of an infectious disease is the
cornerstone for its eventual control. For example, the outbreak
of severe acute respiratory syndrome (SARS) was controlled
after the identiﬁcation of the causative agent coronavirus
(SARS-CoV) (1). Developments in molecular biological
approaches in recent years have led to the identiﬁcation of
many unknown pathogens. Once a fragment from the agent’s
genome has been isolated and sequenced, standard genomic
walking techniques are used to extend the known sequence,
and computer homology searches can then be used to identify
the likely phylogenetic relationship of the agent with other
known organisms (2). Additionally, sequences of some vir-
uses, such as SARS-CoV, have altered during transmission,
and this may prevent the detection of the virus by a PCR
method (3,4). Thus, a detection method that is not based on
the known sequence is essentially required as an alternative
method to the normal PCR method.
Representational difference analysis (RDA) is one of the
most reliable methods for identifying new agents since it does
not require prior knowledge of the agent’s class (5). The tech-
nique is based on PCR enrichment of DNA fragments that
are present in agent-infected cells but absent in normal cells.
Using RDA, Chang et al. (6) isolated two DNA fragments
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doi:10.1093/nar/gni064from a Kaposi’s sarcoma (KS) lesion in an AIDS patient. The
determination of sequences of these fragments resulted in
the discovery of the KS-associated herpes virus (7). Despite
the factthat RDAhasbeen developedfordetecting agents with
a DNA-based genome, it can be used to detect the presence or
absence of RNA in a sample by generating a cDNA interme-
diate (cDNA RDA) to amplify the RNA (8). Since a large
quantity of ribosomal RNAs interfere with cDNA RDA, the
cDNA intermediate should be synthesized from poly(A)
+
RNA. Therefore, it is difﬁcult to detect RNA viruses from
virus-infected cells by cDNA RDA because many viruses
have no poly(A) at the end of the genome. If cDNA RDA
can be applied to total RNA without interference with ribo-
somal RNAs, the virus genome can be ampliﬁed from total
RNA of virus-infected cells by cDNA RDA.
The selection of poly(A)
+ RNA by using an oligo(dT) col-
umn followed by oligo(dT) priming can eliminate the inﬂu-
ence of ribosomal RNAs on cDNA synthesis. Primers that are
speciﬁc to a viral genome also efﬁciently eliminate the inﬂu-
ence of ribosomal RNAs. However, prior knowledge of the
virus genome is required for the construction of speciﬁc pri-
mers. In this study, based on the fact that cDNA can be primed
with a mixture of oligomers, we constructed a set of oligomers
that was inefﬁcient for priming ribosomal RNAs but that
normally primed most of the genome of an RNA virus
(9,10). Based on the frequency distribution of hexanucleotides
in ribosomal RNAs and viral sequences in current public data-
bases, we determined a mixture of 96 hexanucleotides that
rarely prime ribosomal RNAs but can prime all the known
mammalian viruses listed in public databases. The results of
this study show that species-independent detection of viral
RNA from infected cells is possible.
MATERIALS AND METHODS
Design and synthesis of a primer mixture
A rat primary transcript, including 18S, 5.8S and 28S ribo-
somal RNA (V01270.1), was selected for hexanucleotide fre-
quency analysis of ribosomal RNAs. Genomic sequences of
SARS-CoV (AY291315) and bovine parainﬂuenza virus 3
(BPI3, NC_002161) were also selected as representatives of
RNA virus (11). We created three programs, GREG, GAS and
OSC (produced by C’s Labs, Sapporo, Japan and licensed
by Sigma–Aldrich Co. Ltd, St Louis, MO), connected to a
MySQL database server (version 4.0.20). The program
GREG transformed FASTA-formatted sequence to a text-
formatted sequence and inserted it into a table in the
MySQL database (GREG table). Using these programs, we
designedamixtureofhexanucleotideprimers.First,sequences
were divided into hexamers, and each hexamer was classiﬁed
into a pattern of hexanucleotide sequence in which 4
6 = 4096
patterns were included. The program GAS generated fre-
quency distributions of hexanucleotides in the sequences in
the GREG table, extracted the progeny with their probabilities
of hexanucleotide patterns and inserted them into a table (GAS
table) of the database. We made four sets of GREG and GAS
tables for rat ribosomal RNAs, a satellite repeat, BPI3 and
SARS-CoV (Table 1). The program OSC listed the differences
between the two GAS tables, i.e. the program selected oligo-
mer patterns that exist in BPI3 but not in ribosomal RNAs.
The frequency of hexamer patterns in each RNA sequence was
transferred into a table of Microsoft Access. A total of 96
hexamer patterns, including those having very low frequencies
or those that did not appear in ribosomal RNAs, were
synthesized and mixed for use as an RT primer (Table 2,
non-ribosomal hexanucleotides).
Database for mammalian viral genomic data
To estimate the frequencies of priming sites with the selected
hexanucleotides, we prepared a MySQL table that included
sequence data of reported viral genomes as follows. First, we
downloaded all viral sequences from the FTP site of EMBL
database (release date 30 June 2004) and entered them into
tables (EMBL data table) of the MySQL database. The table
included EMBL ID, title, annotation and sequence as ﬁelds.
The annotation ﬁeld included taxonomic classiﬁcation of the
origin of the data. We separated the words included in the
annotation ﬁeld into taxonomic words, such as family names,
and inserted them into a new table (taxonomic table), in which
EMBL IDs and taxonomic words were included. We then
selected EMBL IDs of mammalian viruses with any of the
viral family names listed in Table 5 from the taxonomic table.
Next, sequences of mammalian viruses were divided into
groups according to their species presented in the taxonomic
table. To determine the targets for hexanucleotide analysis,
EMBL IDs having the longest sequence in the species were
selected as the estimated genomic sequence of the virus, and
then, a new table named ‘Sequences of viral species’ was
prepared. Although the longest sequence from each species
was selected, some of these sequences were very short. There-
fore, we eliminated sequences that were shorter than half of
the common genomic size of each viral family. The resultant
1791viral sequences were inserted into atable titled’Genomic
sequenceofviralspecies’.Thefrequencyofthenon-ribosomal
hexanucleotides was determined in sense and complementary
Table 1. Probabilities of hexanucleotide patterns in ribosomal RNAs
(V01270), a satellite-repeat (V00125), SARS coronavirus (SARS-CoV,
AY291315) and bovine parainfluenza virus 3 (BPI3, NC_002161)
Pattern Probability (·10
 3)
Ribosomal RNA Satellite repeat BPI3 SARS-CoV
TCTCTC 13.54 1.28 0.25 0.11
AGAGAG 7.53 0.64 0.63 0.16
GAGAGA 7.11 1.92 0.25 0.11
CTCTCT 6.85 0.64 0.33 0.11
TCTGTC 5.67 0.00 0.28 0.25
CTTTCT 4.68 0.32 0.43 0.67
TCTTTC 4.55 0.00 0.46 0.52
TCTCTG 3.55 0.00 0.48 0.21
GTCTCT 3.43 0.64 0.28 0.21
TGTTAA 0.01 0.00 0.43 0.96
GGTCTA 0.01 0.32 0.15 0.16
ATATAT 0.00 0.00 0.96 0.13
GTGCAC 0.00 0.00 0.00 0.27
TAGTAT 0.00 0.00 0.38 0.16
GATATC 0.00 0.00 0.25 0.13
ATACTA 0.00 0.00 0.30 0.28
TATAGT 0.00 0.00 0.35 0.17
TATATA 0.00 0.00 0.81 0.05
ACTATA 0.00 0.00 0.61 0.31
The hexanucleotide patterns are aligned according to the probabilities in ribo-
somalRNAs.The10highestandlowestfrequentpatternsarelistedinthetable.
A full version of the table, including all patterns, is supplemented online.
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sequence of viral species’.
Culture of virus-infected cells and RNA extraction
The strains SARS-CoV and BPI3 were Frankfurt1 and
BN-1, respectively (12–14). SARS-CoV and BPI3 were
propagated by serial infection of Vero E6 and MDBK cells,
respectively (15).
Vero E6 cells were routinely subcultured in 75 cm
2 ﬂasks
in DMEM (Sigma–Aldrich) supplemented with 0.2 mM/ml
L-glutamine, 100 U/ml penicillin, 10 mg/ml streptomycin
and 5% (v/v) fetal bovine serum (FBS) and maintained at
37 C in an atmosphere of 5% CO2. For experimental use,
the cells were split once in 25 cm
2 ﬂasks and cultured until
they reached 100% conﬂuence. Prior to the virus infection, the
culture medium was replaced with 2% FBS containing
DMEM. SARS-CoV, which was isolated as Frankfurt1 and
kindly provided by Dr J. Ziebuhr (16), was used in the present
study. The viral infection was established in the cells with a
multiplicity of infection (m.o.i) of 10. The infection of cells
with SARS-CoV virus and the subsequent treatment of SARS-
CoV RNA were restricted in the P4 area in the National
Institute of Infectious Disease, and the work with SARS-
CoV was performed in accordance with the rules for infectious
pathogens that have been notiﬁed by the National Institute of
Infectious Disease.
MDBK cells were maintained in Eagle’s minimum essential
medium (Sigma–Aldrich) supplemented with 5% FBS in a
humidiﬁed atmosphere of 5% CO2 at 37 C. The cells were
infected with BPI3 at an m.o.i of 0.1. The work on infection of
BPI3 was performed in accordance with the rules for patho-
gens that have been notiﬁed by Rakuno Gakuen University.
Extraction and in vitro synthesis of RNA
Total RNA was isolated using Trizol (Invitrogen, Carlsbad,
CA) according to the manufacturer’s instructions. Prior to
cDNA synthesis, contaminated genomic DNA in the extracted
RNA was digested with RNase-free DNase I (Promega,
Madison, WI) at 37 C for 1 h. RNA was extracted serially
with phenol and chloroform, precipitated with ethanol accord-
ing to the standard protocol and subsequently used as a control
RNA.
For the synthesis of a model RNA, the entire molecule of
pCIneo plasmid was transcribed in vitro from a T7 promoter.
The synthesized 5.4 kb RNA was treated with RNase-
free DNase I (Promega), extracted with phenol/chloroform,
precipitated with ethanol and subsequently used as a test
RNA. After quantitation, the test and control RNAs were
mixed to estimate the sensitivity of cDNA RDA in various
conditions.
cDNA RDA
First-strand cDNA was synthesized from the mixed RNA with
non-ribosomal hexanucleotides by using a double-stranded
cDNA synthesis kit (Invitrogen) according to the manufac-
turer’s protocol, i.e. the total RNA was diluted to 1 mg per ml
and mixed with dNTPs, the non-ribosomal hexanucleotides,
5· reaction buffer, 0.1 M DTT and an RNase inhibitor.
Reverse transcriptase (Superscript II, Invitrogen) was
added, and the mixture was incubated at 50 C for 60 min.
Second-strand cDNA was synthesized with Escherichia coli
DNA polymerase (Invitrogen), E.coli DNA ligase (Invitrogen)
and RNaseH (Invitrogen) at 16 C for 2 h. Double-stranded
cDNA was digested with Dpn II, and the resultant fragments
were extracted from the digest by using a silicon-membrane-
based puriﬁcation kit (Gene Elute Puriﬁcation Kit; Sigma–
Aldrich).
Linker-derived ampliﬁcation of DNA fragments and select-
ive ampliﬁcation steps of cDNA RDA were performed accord-
ing to the method described by Hubank and Schatz (17).
Brieﬂy, 0.1 mg of Dpn II-digested double-stranded cDNA
was ligated with RBam24 and RBam12 linkers (5). An aliquot
of 1 ml of the ligation solution was diluted with Taq mixture
(10mlof10·Taqbuffer,including15mMMgCl2,and0.2mM
each of dNTPs). The mixture was preheated to 72 C, and then,
Taq polymerase (Promega) was added and the mixture was
incubated at 72 C for 5 min to synthesize a complementary
strand against the overhanging region of RBam24. This was
immediately followed by a denaturation step (94 C for 2 min)
and 20 cycles of PCR (94 C for 1 min and 72 C for 8 min)
tonon-speciﬁcallyamplify 200–800bp DpnII-digestedcDNA
fragments with linkers (amplicons). After ampliﬁcation,
amplicons were redigested with Dpn II and puriﬁed with a
silicon-membrane-based puriﬁcation kit to eliminate the
spliced linkers. Some amplicons, including the test RNA,
were religated with JBam24 and JBam12 linkers. Amplicons
with the second linkers were mixed with a large quantity of
amplicons without the test RNA sequences.
Table 2. Hexanucleotide patterns of non-ribosomal hexanucleotides
Motif Motif Motif Motif Motif Motif Motif Motif
GATATC GATACT CGATAT ACTACT ATAGTC CTTAGT ACTAAG AACTTA
TAGTAT CGTATA GTATAC TAACGA CTAGTA CTTACA GCATAC ATAACG
TATAGT GTATAG AATCCA CGACTA GTACTA TTATGC CAATAT ATGTTA
TATATA CGGTTA TAGCAC TACTAG TAAGTT ATACGC ACCGTA TGGTAT
ATACTA AATAGT ATATCG AGTAGT ATATCC CGCTTA GTGCTA TGCGTA
ATATAT CGCATA AATATT GTTAAC TCGATA TAACGC ACGCTA GGATAT
GTGCAC ATTACG TATAGC GTCTAC GTACCA GGTCAT ATGTCG CATAGC
ACTATA TTAACA CTTGTA TACAAG GTATCA CTCATA AGCTTA CATACT
CGTAAT AGTATC TAGTCG TACCAG ATACTC AATTTG CGACAT CGGATA
CTATAC TGTTAA GTAGAC TGGATT ACATTA CTGGTA GCTATA TTACTA
TATACG ACTATT CTATAG TCGTTA ATATTG TTCATG GCTATG ACTCGT
TATGCG TAACCG TAGCTA ATAGTA CGTCTA GCGATA TGTAAG TAAGGT
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acetate, dissolved in4mlof3·EE buffer f30 mM EPPS [N-(2-
hydroxyethyl)piperazine-N0-3-propanesulfonic acid], 3 mM
EDTA, pH 8.0g and covered with mineral oil. After the
mixture was heated to 99 C for 4 min, 1 ml of 5 M NaCl was
added, and the solution was incubated at 67 C for 21 h. During
this incubation period, amplicons from normal cellular RNA
withalinkerincludedinthetestampliconswerehybridizedwith
those from uninfected cells without a linker. After hybridiza-
tion, the reaction mixture was diluted to 100 ml with reaction
buffer of Taq DNA polymerase (Promega) as described above.
Amplicons having the linker sequence at both ends were
ampliﬁedbyadenaturationstep(94 Cfor2min)and20cycles
of PCR (94 C for 1 min and 72 C for 3 min).
RNAs extracted from virus-infected cells were subjected to
cDNA RDA as described above, by using amplicons synthes-
ized from RNA obtained from uninfected cells.
Southern blot hybridization
cDNA RDA-derived fragments in quantities ranging from
1 0 0n gt o2mg were separated on agarose gels, blotted onto
a Biodyne nylon membrane (Pall Co. Ltd, Port Washington,
NY) by capillary transfer in 20· SSC (3 M sodium chloride
and 0.3 M sodium citrate) for 16 h and ﬁxed to the membrane
by baking in an oven at 80 C for 30 min. pCIneo was used as
a probe for the in vitro synthesized RNA. A random primer
labelling kit (BcaBest Labeling kit, Takara Shuzo Co. Ltd,
Kyoto, Japan) was used for labelling with
32P and hybridized
in SuperHybPlus hybridization solution (Sigma–Aldrich)
according to the manufacturers’ protocol.
Although amplicons are cloned into a vector to identify its
sequence, according to ‘Cartagena Protocol on Biosafety Text
of the Protocol’, amplicons from SARS-CoV-infected cells
should not be cloned into any plasmid. Therefore, by perform-
ing hybridization, we identiﬁed that the sequences of amplic-
ons derived from SARS-CoV-infected cells were identical to
SARS-CoV. To determine probes for SARS-CoV, the PCR
products predicted from the genomic sequence and sizes of
cDNA RDA products were ampliﬁed from the SARS-CoV
genome. These PCR products were puriﬁed, labelled with
DIG and independently hybridized using a slit of the nylon
membrane blotted with amplicons derived from SARS-CoV-
infected cells. DIG labelling and hybridization were carried
out according to the manufacturer’s instructions provided
with the DIG-hybridization kit (F. Hoffmann-La Roche Ltd,
Diagnostics Division, Basel, Switzerland). Hybridization was
carried out with DIG-labelled DNA probes at 65 C for 16 h
in DIG-hybridization solution.
Cloning and sequence analysis
The cDNA RDA-derived fragments were respliced with
Dpn II, separated on agarose gels, extracted with a silicon-
membrane-based puriﬁcation kit and cloned into pSPORT1
(Invitrogen). Plasmids that included cDNA RDA-derived
fragments were selected by colony PCR and puriﬁed with a
silicon-membrane-based puriﬁcation kit. Three clones of the
plasmid were sequenced along with the fragment to detect
PCR errors. Sequences of the cDNA RDA-derived fragments
were determined using a DYEnamic ET-terminator kit
(Amersham Biosciences Corp., Piscataway, NJ) and an ABI
Prism 310 sequencer (PerkinElmer Life and Analytical
Sciences, Inc., Boston, MA) with M13 forward and reverse
primers (Takara Shuzo). We used the BLAST program on
NCBI to determine sequences that were homologous to the
isolated fragments.
RESULTS
Frequency distribution of hexanucleotides within the
ribosomal sequences
To predict the major RNA molecule in cellular RNA, we
synthesized cDNA from RNA extracted from normal bovine
cells, synthesized amplicons by using random primers, spliced
them with Dpn II and ﬁnally subcloned them into pSPORT1.
Among the sequences of 30 selected clones, the sequences of
25 clones and 5 clones were highly homologous to those of
ribosomal RNA and a 1399 bp satellite repeat (GenBank
accession no. V00125), respectively. Based on this result,
ribosomal and satellite sequences were determined for analys-
ing hexanucleotide frequency. Since the reported ribosomal
sequences of mammals are highly homologous to each other,
we selected rat premature 18S, 5.8S and 28S ribosomal
sequences as ribosomal sequences for hexanucleotide fre-
quency analysis. Genome sequences of SARS-CoV and
BPI3 were selected as representatives of RNA viral sequence.
Table1showsthe probabilities[numberofthe patterns/(length
of sequence · 2)] of hexanucleotides in the human ribosomal
RNA, V00125 satellite repeat, BPI3 and SARS-CoV. If a
randomsequence isassumed,frequencies would be distributed
according to the Poisson’s distribution, and the average of
frequency would be the same as the variance of frequency.
Although the average/variance ratios of all the four sequences
were <1, the ratio of ribosomal RNA was smallest in these
sequences (Table 3). This value suggests that the probabilities
of hexamer patterns of ribosomal RNA were strongly biased
from random sequence. Based on histograms of probabilities,
the distribution of the probabilities of hexamer patterns in
ribosomalRNAdiffered greatlyfromthoseofV00125satellite
repeat or BPI3 (Figure 1). It should be noted that 8 hexanuc-
leotides did not exist and over 90 hexanucleotides were rare in
the ribosomal sequence. To determine primer sequences that
do not prime ribosomal RNA but prime viral RNA, the prob-
abilities of hexamer patterns in ribosomal RNA and satellite
repeat were calculated. The hexamer patterns were then
realigned in an ascending order according to the sum of
probabilities, and the 1st to 96th patterns were selected as
non-ribosomal hexanucleotides, i.e. we selected 96 rarest
hexanucleotide patterns (Table 2, non-ribosomal hexanuc-
leotides) in major transcripts in normal mammalian cells on
the assumption that ribosomal RNA and transcripts from satel-
lites are the most frequent transcripts in normal cells.
Table 3. Average and variances of frequencies of hexanucleotide patterns in
ribosomal RNAs, a satellite repeat (V00125), bovine parainfluenza virus 3
(BPI3) and SARS coronavirus (SARS-CoV)
Ribosomal RNAs Satellite repeat BPI3 SARS-CoV
Average 26.8 1.9 10.6 18.6
Variance 2156.5 2.5 96.0 188.1
Average/variance 0.012 0.76 0.11 0.099
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with non-V00125-satellite and random hexamers was
conﬁrmed in reported sequences of mammalian ribosomal
RNAs (Table 4). The probabilities were relatively low in
all the mammalian ribosomal sequences reported in GenBank.
It is considered that non-ribosomal hexanucleotides inefﬁ-
ciently primed ribosomal RNAs in reverse transcription. On
the other hand, the probabilities of non-ribosomal, non-
V00125-satellite or random hexamers were different among
the satellite sequences.
Frequencies of non-ribosomal hexanucleotides
in viral genomic sequences
In addition to the inefﬁciency to prime ribosomal RNAs,
efﬁcient priming of V00125-satellite-repeat and BPI3 with
non-ribosomal hexanucleotides is shown in Figure 1. To pred-
ict priming efﬁciency in many viruses, the probability of
non-ribosomal hexanucleotides in known viral genomes was
estimated. In 1791 viral sequences in ‘Genomic sequences of
viral species’, the median probabilities of non-ribosomal hexa-
nucleotides of all known viral sequences is 13.2–37.6 · 10
 3
(Table 5). When the average probabilities were calculated in
viral families, the minimum probability was 3.7 · 10
 3 in
Herpesviridae and the maximum probability was 44.8 · 10
 3
in Poxviridae (Table 5). These median values of probabilities
in viral genomes were greater than those of ribosomal
RNAs (Table 4) and comparable with those of non-V00125
and random hexamers (Table 5). These data suggest that
non-ribosomal hexanucleotides prime cDNA synthesis in
most viruses.
Model experiment for differentiated amplification
of viral RNA by cDNA RDA
The database analysis suggests that viral RNAs were efﬁ-
ciently primed by non-ribosomal hexanucleotides in compar-
ison with ribosomal RNAs. We investigated the effect of
non-ribosomal hexanucleotides on cDNA synthesis by using
in vitro synthesized plasmid RNA (artiﬁcial RNA) and total
cellular RNA, including ribosomal RNAs. An autoradiogram
of
32P-labelled double-stranded cDNAs that were synthesized
using non-ribosomal hexanucleotides or a random primer and
subsequently separated by agarose gel electrophoresis is
shown in Figure 2. When test and total cellular RNAs were
reverse transcribed individually, the efﬁciencies of cDNA syn-
thesis from artiﬁcial RNA using random and non-ribosomal
hexanucleotides were almost similar; however, the efﬁciency
of cDNA synthesis of cellular RNA was markedly lower in
a non-ribosomal hexanucleotide-primed cDNA sample than in
a random primer-primed cDNA sample (Figure 2A). In the
mixed samples of test and total cellular RNAs, ribosomal
RNAs were inefﬁciently reverse transcribed with non-
ribosomal hexanucleotides. The total incorporated counts in
non-ribosomal hexanucleotides-primed cDNAs decreased
with a decrease in the proportion of the test RNA in the
mixed RNA samples (Figure 2A). It is considered that the
efﬁciency of reverse transcription depends on the proportions
of the test RNA in the mixed RNAs. When approximately the
same counts of cDNAs were loaded on the gel, synthesis
of ribosomal RNA-derived cDNA (ribosomal cDNA) was
obvious in random primer-primed cDNAs (Figure 2B).
Figure 1. Histogram of probabilities of hexanucleotide patterns in ribosomal
RNAs (A), a satellite repeat (B), BPI3 and SARS-CoV (C). From each
sequence, the frequency was determined for each hexanucleotide pattern by
usingprogramsdescribedinMaterialsandMethods.Probabilitywascalculated
as (frequency of a motif/total length of sequence). For simple comparison,
the probabilities of ribosome RNAs and satellite repeat or SARS-CoV and
BPI3 were added for each hexanucleotide pattern. Hexanucleotide patterns
were aligned according to their probability in the ribosomal RNAs. When
the probabilities of hexanucleotide patterns were larger than 0.005, the data
were omitted.
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e65 Nucleic Acids Research, 2005, Vol. 33, No. 6 PAGE 6 OF 11Table5.Numberofspeciesandmaximum,minimumandmedianprobabilities[median(minimum maximum)](·10
 3)ofnon-ribosomal,non-V00125-satellite-
repeat and random hexamers hexanucleotides in known viral species
Family Number of species Non-ribosomal Non-V00125 Random hexamers
Adenoviridae 25 15.3 (6.5–28.3) 25.0 (19.4–47.1) 23.8 (22.8–47.6)
Arenaviridae 8 17.0 (13.1–19.2) 26.0 (23.3–27.6) 24.5 (23.8–25.1)
Astroviridae 7 17.4 (14.5–19.2) 23.9 (22.4–25.6) 24.3 (23.5–25.2)
Bornaviridae 1 20.0 (20.0–20.0) 21.8 (21.8–21.8) 23.7 (23.7–23.7)
Bunyaviridae 26 22.8 (11.8–30.7) 26.2 (21.8–29.7) 23.7 (23.1–25.3)
Caliciviridae 23 13.2 (7.1–19.3) 23.5 (19.1–26.5) 24.1 (23.4–25.4)
Coronaviridae 51 24.2 (23.9–31.4) 25.3 (25.2–29.9) 23.6 (23.5–24.3)
Filoviridae 3 21.9 (20.8–22.6) 24.9 (24.4–26.2) 25.0 (24.5–25.1)
Flaviviridae 53 14.1 (8.6–23.4) 22.4 (19.0–25.9) 24.0 (21.6–25.2)
Hepadnaviridae 14 16.6 (9.7–27.2) 21.6 (18.0–25.3) 24.0 (21.3–24.5)
Herpesviridae 31 15.0 (3.7–29.2) 22.6 (16.4–27.2) 23.5 (22.8–24.5)
Iridoviridae 3 17.7 (14.1–25.2) 23.3 (20.8–29.3) 23.5 (21.9–23.6)
Orthomyxoviridae 1029 17.6 (6.3–29.7) 24.3 (16.2–32.9) 24.3 (20.0–27.9)
Papillomaviridae 123 24.7 (7.7–34.3) 24.9 (18.7–28.9) 23.2 (21.1–25.0)
Parvoviridae 59 20.5 (6.3–35.9) 25.0 (19.5–31.2) 23.8 (21.6–25.1)
Picornaviridae 90 19.3 (7.1–30.6) 24.3 (19.0–29.0) 24.0 (22.6–25.1)
Polyomaviridae 16 18.4 (14.0–28.5) 22.0 (20.6–26.4) 23.6 (22.3–24.7)
Poxviridae 21 37.6 (8.2–44.8) 26.9 (22.7–32.0) 22.9 (21.3–24.0)
Reoviridae 89 28.4 (12.9–38.4) 26.2 (19.2–31.5) 23.8 (20.7–25.8)
Retroviridae 86 17.0 (9.9–27.6) 22.1 (18.2–26.8) 23.3 (21.6–24.6)
Rhabdoviridae 14 16.8 (9.2–25.3) 22.7 (19.0–26.3) 23.6 (23.1–24.2)
Togaviridae 19 20.0 (7.6–24.3) 23.3 (20.1–25.1) 23.7 (22.7–24.5)
Sequences for species were selected according to their length as described in Materials and Methods. The total probability in each species was calculated as the
summationofprobabilitiesofallnon-ribosomalhexanucleotidesinsenseandcomplementarysequencesofaviralgenomicsequencethatwasselectedasdescribedin
Materials and Methods. The probabilities of non-ribosomal hexanucleotides in 1791 virus genomic sequences are supplemented online.
Figure 2. Autoradiogramof
32P-labelleddouble-strandedcDNAsynthesizedfrommixturesconsistingofartificialRNAandtotalcellularRNA.Invitrotranscribed
RNAwassynthesizedfrompCIneoplasmidandmixedwithtotalcellularRNAextractedfromrat2cellsinweightproportions1:0(lanes1and8),1:1(lanes2and9),
1:10 (lanes 3 and 10), 1:100 (lanes 4 and 11), 1:300 (lanes 5 and 12), 1:1000 (lanes 6 and 13) and 0:1 (lanes 7 and 14). One microgram of mixed RNA was reverse
transcribed using random (lanes 1–7) or non-ribosomal (lanes 8–14) hexanucleotides and a second-strand cDNA was then synthesized with RNaseH, DNA
polymerase and DNA ligase according to the method described in Materials and Methods. One-tenth of the volume of synthesized cDNAs was loaded on agarose
gel (A). Loaded volumes were corrected to include the same amounts of
32P in each sample (B). Positions and sizes (bp) of markers are present on the left.
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obvious in the cDNA primed with non-ribosomal hexanuc-
leotides. A relatively large cDNA derived from artiﬁcial
RNA could be observed even when a smaller proportion of
test RNA was mixed with cellular RNA and non-ribosomal
hexanucleotide-primed samples. These data suggest that the
relative amount of test RNA-derived cDNA is greater
in non-ribosomal hexanucleotides-primed samples than in
random primer-primed samples.
After the ﬁrst round of cDNA RDA, ampliﬁed fragments
were observed on agarose by staining with ethidium bromide.
The bands that corresponded to artiﬁcial RNA could be
observed in 1:0, 1:1 and 1:10 (test:total cellular RNAs) mix-
tures when cDNAs were primed with a random primer. On the
otherhand, thesebands could be observed in1:0to1:300 RNA
mixtures when cDNA was primed with non-ribosomal hexa-
nucleotides (Figure 3A). This ampliﬁcation of test RNA was
conﬁrmedbyhybridizationwith pCIneo, which wasatemplate
for in vitro RNA synthesis (Figure 3B). The hybridized bands
were observed even in a lane corresponding to 1:1000 RNA
mixture. When cDNA was primed with a random primer, the
hybridized bands could not be observed in 1:100, 1:300 and
1:1000 RNA mixtures. These data suggest that the lower limit
of the test RNA ampliﬁcation decreased at least 30 times
when non-ribosomal hexanucleotides were used for reverse
transcription when compared with the data obtained by
using a random primer.
Detection of BPI3 and SARS-CoV sequences
from infected cell RNA
To amplify virus sequence from infected cells, we subtracted
amplicons derived from uninfected cells from those derived
from virus-infected cells. Ampliconswithlinkers derived from
the infected cells were mixed with amplicons without linkers
Figure 3. Agarose gel electrophoresis of RDA products (A) and its hybridized autoradiogram (B). In vitro transcribed RNA and total cellular RNA were mixed as
described in the legend to Figure 2. Double-stranded cDNAs were synthesized and subjected to RDA as described in Materials and Methods. One-twentietho f
the volume of the amplified products was separated on 3% agarose gel and stained with ethidium bromide (A), blotted onto a nylon membrane and hybridized with
32P-labelled pCIneo (B). Positions and sizes (bp) of markers are present on the left.
Figure 4. Agarose gel electrophoresis of RDA products from RNA
extracted from bovine parainfluenza virus 3-infected cells. Double-stranded
cDNA was synthesized from RNA of bovine parainfluenza virus 3-infected
MDBK cells and subjected to RDA. Mock-infected cells were used for the
synthesis of driver amplicons for RDA. One-twentieth of the volume of the
amplified products was separatedon 3% agarose gel and stained with ethidium
bromide.RDAproductfromtheuninfectedcontrolcellswasusedasanegative
control.
e65 Nucleic Acids Research, 2005, Vol. 33, No. 6 PAGE 8 OF 11derived from uninfected cells at the ratio of 1:100 before a
hybridization step of cDNA RDA. At the end of the ﬁrst round
of cDNA RDA, the ladders of ampliﬁed fragments were
generated from BPI3-infected cells when non-ribosomal hexa-
nucleotides were used (Figure 4). No cDNA RDA-derived
bands were obvious when a random primer was used for
reverse transcription (data not shown). Ampliﬁed fragments
from cDNA RDA of BPI3-infected cells were cloned into
pSPORT1 plasmid, and the sequences were determined.
The sequences of all the cloned fragments from cDNA
RDA were identical to the sequence of the BPI3 genome.
These data suggest that cDNA RDA with non-ribosomal hexa-
nucleotides enables the identiﬁcation of the BPI3 genome
sequence from infected cells.
Similar to BPI3, cDNA fragments derived from SARS-CoV
were also ampliﬁed from SARS-CoV-infected cells(Figure 5).
Viral origin of the ampliﬁed fragments was conﬁrmed by
hybridization (Figure 5B) and PCR ampliﬁcation by SARS-
CoV-speciﬁc primers (Figure 5A). These results indicate that
genomic fragments of SARS-CoV can also be isolated by this
method.
DISCUSSION
Reduction of influence of ribosomal RNA on cDNA
synthesis by non-ribosomal hexanucleotides
It is well known that 3–5% and 30% of cellular RNA are
estimated to be messenger and ribosomal RNA, respectively.
The frequency of ribosomal RNA has been estimated by
competitive PCR and real-time PCR to be 10 000 copies
per cell (18). The amount of ribosomal RNA has been reported
to be 1000-fold greater than that of frequently transcribed
mRNA, such as beta actin and G6PDH. Thus, the repertoire
of cDNA would be strongly affected by ribosomal RNA. This
inﬂuence of ribosomal RNA has been avoided by oligo(dT)
selection. Alternative strategy for the elimination of ribosomal
RNA from total RNA, however, has not been developed.
Therefore, there have been only a few applications of
cDNA RDA for non-poly(A) RNA, such as those in viral
genomes. In this study, we developed a new strategy for
the elimination of ribosomal RNA in cDNA RDA through
the construction of a hexanucleotide mixture and demon-
strated its efﬁciency in cDNA RDA.
ThemainpurposeofPCRisspeciﬁcampliﬁcationofagene.
However, methods using multiple primers for simultaneous
gene ampliﬁcation have been recently employedfor DNA chip
methods. In order to simultaneously detect multiple genes by
using a DNA chip, mixed oligonucleotides have been used as a
primer for reverse transcription. This usage of mixed primers
wasbasedontheassumptionthatthespeciﬁcityofprimers was
equal to the summation of the speciﬁcity of each primer. Thus,
we searched for primers that do not prime ribosomal RNAs by
frequency analysis of hexanucleotides. The frequency and
distribution of oligonucleotides in mammalian and viral gen-
omes have been studied to search for common motifs that
might be used for controlling cellular functions (19–23).
Volinia et al. (22) found sets of common decamers that can be
used for the control of transcription control signals or for the
common ampliﬁcation of viruses. Programs for frequency
Figure5.AgarosegelelectrophoresisofRDAproductswithPCRproductsusedforprobesforhybridization(A)andahybridizedfluorogram(B).RNAwasextracted
fromSARS-CoV-infectedcellsandsubjectedtoRDAaccordingtothemethoddescribedinMaterialsandMethods.Mock-infectedcellswereusedforthesynthesisof
driver amplicons for RDA. One-twentieth of the volume of the amplified products was separated on 3% agarose gels and blotted on a Nylon membrane. The
membranewas thencut into slits that contained the lane showing the presenceof DNA.On the other hand, the PCR fragments predictedto be amplifiedin the RDA
reaction were amplified and subsequently ascertained by agarose gel electrophoresis (A). The amplified genomic fragments of SARS-CoV were Dig-labelled and
usedasprobesforhybridizationtoeachslitoftheNylonmembranecontainingtheRDAproduct.Hybridizationwasperformedinseparatehybridizationbags.After
washing with 1· SSC and 0.1% SDS solution, the hybridized probes were detected on a fluorogram (B). Positions and sizes (bp) of markers are present on the left.
PAGE 9 OF 11 Nucleic Acids Research, 2005, Vol. 33, No. 6 e65analysis have been useful for searching common oligonuc-
leotides in many subsets of sequences. On the other hand,
database programming is useful not only for searching com-
mon oligonucleotides but also for searching oligonucleotides
thatdonotexistinasubsetofsequences.Inthisstudy,wefound
that there were hexanucleotide patterns that were rare or that
didnotexistinribosomalRNAsequences.Wealsoshowedthat
sequences of 96 selected non-ribosomal hexanucleotides are
normally present in known viral sequences (Table 5).
Improvement of detection efficiency of
extracellular RNA on cDNA RDA
In the experiment for the determination of the effect of non-
ribosomal hexanucleotides, we used a mixture of artiﬁcially
synthesized andtotalcellularRNAs.Theprobabilitiesofhexa-
nucleotide patterns in the sequence of pCIneo was different
fromribosomalRNA(18.4·10
 3,22.4·10
 3and23.0·10
 3
for non-ribosomal, non-V00125 and random hexamers,
respectively). The artiﬁcially synthesized RNA included
30 priming sites for non-ribosomal hexanucleotides and was
efﬁciently reverse transcribed (Figure 2). In the model experi-
ments, cDNA RDA with non-ribosomal hexanucleotides efﬁ-
ciently reverse transcribed and speciﬁcally ampliﬁed the
extracellular test RNA in the mixed RNA (Figure 3). cDNA
RDA-derived detection of the artiﬁcial RNA was 30-fold more
sensitive when non-ribosomal hexanucleotides were used than
when random hexamers were used. These results suggest that
non-ribosomal hexanucleotides dramatically improve the
detection efﬁciency of cDNA RDA.
Application of non-ribosomal hexanucleotides
for viral detection
The common existence of non-ribosomal hexanucleotides in
known viral genomes (Table 5) and the improved sensitivity
for the ampliﬁcation of a non-ribosomal sequence in the mixed
RNAs (Figure 3) suggest that non-ribosomal hexanucleotides
could be used for non-speciﬁc detection of a viral sequence in
infected cells. However, the sensitivity for sequence detection
may be low when compared with that of common PCR
using speciﬁc primers. Thus, the usage of this method
might be restricted to infected cells that contain many copies
of a virus.
The copy number of RNA viruses is dependent on the virus
species, host cells and replicative and productive state of vir-
uses. In our experiment, we detected 3 ng of contaminated
RNAs in 1 mg of total RNA. Although this sensitivity is con-
siderably lower than that of normal PCR, our experiments on
SARS-CoV and BPI3 suggest that the sensitivity of cDNA
RDA with non-ribosomal hexanucleotides is sufﬁcient to
detect these viruses in productively infected cells. Addition-
ally, this method can be applied to most productive viruses,
since sense and complementary sequences of non-ribosomal
hexanucleotideswere foundtoexistinmostoftheknownvirus
sequences in GenBank (Table 5). In conclusion, this method
could be applied as an alternative method for the detection of
any emerging viruses.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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